Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease.
- A. Petralito, R. Mangiafico, S. Gibiino, M. A. Cuffari, M. Miano, C. Fiore
- Medicine, BiologyChronobiologia
- 1 April 1982
The possibility of occurrence of daily variations in blood fibrinogen levels, platelets aggregation. Howell's time values and values for PTT, TT and antithrombin III was explored in 10 healthy…
Effects of salmon calcitonin on blood glucose and insulin levels under basal conditions and after intravenous glucose load
- A. Petralito, M. Lunetta, A. Liuzzo, C. Fiore, G. Heynen
- Medicine, BiologyJournal of endocrinological investigation
- 1 April 1979
A study of the effects of salmon calcitonin (sCT) infusion on blood sugar and serum insulin levels under basal conditions and after intravenous glucose load in normal subjects is reported. Under…
Beta-thromboglobulin plasma levels in different stages of arterial hypertension.
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
Effects of salmon calcitonin on insulin-induced growth hormone release in man.
Erythrocyte aggregation in different stages of arterial hypertension.
Inotropic effects of calcitonin in man.
- C. Fiore, G. Carnemolla, S. Grillo, D. Grimaldi, A. Petralito
- Medicine, BiologyActa cardiologica
The mechanism by which Calcitonin can modify the myocardial inotropism in the normal subject is till now unknown, and it could be related to the interference of this hormore on the endocellular movements of Calcium, and on the cellular levels of cyclic AMP.
[Behavior of serum gamma glutamyl transpeptidase activity during acute phase of myocardial infarct].
Muzolimine in the Treatment of Arterial Hypertension in the Elderly
The present open trial was designed to investigate the antihypertensive effect of a single oral dose of Muzolimine in a group of overweight, elderly hypertensive patients who are more likely to develop metabolic side-effects on diuretic therapy.